Promoter hypomethylation results in increased expression of protein phosphatase 2A in T Cells from patients with systemic lupus erythematosus

Journal of Immunology

Volumn 186, Issue 7, 2011, Pages 4508-4517

  Sunahori, Katsue ^a   Juang, Yuang Taung ^a   Kyttaris, Vasileios C ^a   Tsokos, George C ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DNA METHYLTRANSFERASE 1; GENOMIC DNA; MESSENGER RNA; PHOSPHOPROTEIN PHOSPHATASE 2A;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DISEASE ACTIVITY; DNA METHYLATION; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ADULT; BASE SEQUENCE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; PROTEIN PHOSPHATASE 2; T-LYMPHOCYTE SUBSETS; UP-REGULATION;

EID: 79955048011     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000340     Document Type: Article

References (65)

1. Sawalha, A. H., and J. B. Harley. 2004. Antinuclear autoantibodies in systemic lupus erythematosus. Curr. Opin. Rheumatol. 16: 534-540. (Pubitemid 39128320)
2. Harley, J. B., J. A. Kelly, and K. M. Kaufman. 2006. Unraveling the genetics of systemic lupus erythematosus. Springer Semin. Immunopathol. 28: 119-130. (Pubitemid 44526313)
3. Järvinen, P., and K. Aho. 1994. Twin studies in rheumatic diseases. Semin. Arthritis Rheum. 24: 19-28.
4. Cooper, G. S., C. G. Parks, E. L. Treadwell, E. W. St Clair, G. S. Gilkeson, and M. A. Dooley. 2004. Occupational risk factors for the development of systemic lupus erythematosus. J. Rheumatol. 31: 1928-1933. (Pubitemid 39336715)
5. Javierre, B. M., A. F. Fernandez, J. Richter, F. Al-Shahrour, J. I. Martin-Subero, J. Rodriguez-Ubreva, M. Berdasco, M. F. Fraga, T. P. O'Hanlon, L. G. Rider, et al.. 2010. Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res. 20: 170-179.
6. Cornacchia, E., J. Golbus, J. Maybaum, J. Strahler, S. Hanash, and B. Richardson. 1988. Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. J. Immunol. 140: 2197-2200. (Pubitemid 18098475)
7. Deng, C., Q. Lu, Z. Zhang, T. Rao, J. Attwood, R. Yung, and B. Richardson. 2003. Hydralazine may induce autoimmunity by inhibiting extracellular signalregulated kinase pathway signaling. Arthritis Rheum. 48: 746-756. (Pubitemid 36302012)
8. Wang, G. S., M. Zhang, X. P. Li, H. Zhang, W. Chen, M. Kan, and Y. M. Wang. 2009. Ultraviolet B exposure of peripheral blood mononuclear cells of patients with systemic lupus erythematosus inhibits DNA methylation. Lupus 18: 1037-1044.
9. Rao, T., and B. Richardson. 1999. Environmentally induced autoimmune diseases: Potential mechanisms. Environ. Health Perspect. 107(Suppl 5): 737-742. (Pubitemid 29527778)
10. Singal, R., and G. D. Ginder. 1999. DNA methylation. Blood 93: 4059-4070. (Pubitemid 29279247)
11. Kass, S. U., D. Pruss, and A. P. Wolffe. 1997. How does DNA methylation repress transcription? Trends Genet. 13: 444-449. (Pubitemid 27479903)
12. Bartolomei, M. S., and S. M. Tilghman. 1997. Genomic imprinting in mammals. Annu. Rev. Genet. 31: 493-525. (Pubitemid 28023717)
13. Nakao, M., and H. Sasaki. 1996. Genomic imprinting: Significance in development and diseases and the molecular mechanisms. J. Biochem. 120: 467-473. (Pubitemid 26331630)
14. Kammer, G. M., A. Perl, B. C. Richardson, and G. C. Tsokos. 2002. Abnormal T cell signal transduction in systemic lupus erythematosus. Arthritis Rheum. 46: 1139-1154. (Pubitemid 34525819)
15. Richardson, B. C., J. R. Strahler, T. S. Pivirotto, J. Quddus, G. E. Bayliss, L. A. Gross, K. S. O'Rourke, D. Powers, S. M. Hanash, and M. A. Johnson. 1992. Phenotypic and functional similarities between 5-azacytidine-treated T cells and a T cell subset in patients with active systemic lupus erythematosus. Arthritis Rheum. 35: 647-662.
16. Lu, Q., M. Kaplan, D. Ray, D. Ray, S. Zacharek, D. Gutsch, and B. Richardson. 2002. Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus. Arthritis Rheum. 46: 1282-1291. (Pubitemid 34525836)
17. Lu, Q., A. Wu, and B. C. Richardson. 2005. Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus-inducing drugs. J. Immunol. 174: 6212-6219. (Pubitemid 40663812)
18. Lu, Q., A. Wu, L. Tesmer, D. Ray, N. Yousif, and B. Richardson. 2007. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J. Immunol. 179: 6352-6358.
19. Richardson, B. C. 2008. Epigenetics and autoimmunity. Overview. Autoimmunity 41: 243-244.
20. Kaplan, M. J., Q. Lu, A. Wu, J. Attwood, and B. Richardson. 2004. Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4+ lupus T cells. J. Immunol. 172: 3652-3661. (Pubitemid 38337948)
21. Kwon, N. H., J. S. Kim, J. Y. Lee, M. J. Oh, and D. C. Choi. 2008. DNA methylation and the expression of IL-4 and IFN-gamma promoter genes in patients with bronchial asthma. J. Clin. Immunol. 28: 139-146.
22. Nile, C. J., R. C. Read, M. Akil, G. W. Duff, and A. G. Wilson. 2008. Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis. Arthritis Rheum. 58: 2686-2693.
23. Mi, X. B., and F. Q. Zeng. 2008. Hypomethylation of interleukin-4 and -6 promoters in T cells from systemic lupus erythematosus patients. Acta Pharmacol. Sin. 29: 105-112.
24. Janson, P. C., P. Marits, M. Thörn, R. Ohlsson, and O. Winqvist. 2008. CpG methylation of the IFNG gene as a mechanism to induce immunosuppression [correction of immunosupression] in tumor-infiltrating lymphocytes. J. Immunol. 181: 2878-2886.
25. Sawalha, A. H., M. Jeffries, R. Webb, Q. Lu, G. Gorelik, D. Ray, J. Osban, N. Knowlton, K. Johnson, and B. Richardson. 2008. Defective T-cell ERK signaling induces interferon-regulated gene expression and overexpression of methylation-sensitive genes similar to lupus patients. Genes Immun. 9: 368-378. (Pubitemid 351791493)
26. Gorelik, G., and B. Richardson. 2009. Aberrant T cell ERK pathway signaling and chromatin structure in lupus. Autoimmun. Rev. 8: 196-198.
27. Deng, C., M. J. Kaplan, J. Yang, D. Ray, Z. Zhang, W. J. McCune, S. M. Hanash, and B. C. Richardson. 2001. Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. Arthritis Rheum. 44: 397-407.
28. Balada, E., J. Ordi-Ros, S. Serrano-Acedo, L. Martinez-Lostao, M. Rosa-Leyva, and M. Vilardell-Tarrés. 2008. Transcript levels of DNA methyltransferases DNMT1, DNMT3A and DNMT3B in CD4+ T cells from patients with systemic lupus erythematosus. Immunology 124: 339-347. (Pubitemid 351793466)
29. Katsiari, C. G., V. C. Kyttaris, Y. T. Juang, and G. C. Tsokos. 2005. Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus. J. Clin. Invest. 115: 3193-3204. (Pubitemid 41567584)
30. Virshup, D. M. 2000. Protein phosphatase 2A: A panoply of enzymes. Curr. Opin. Cell Biol. 12: 180-185.
31. Janssens, V., and J. Goris. 2001. Protein phosphatase 2A: A highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem. J. 353: 417-439. (Pubitemid 32158309)
32. Lechward, K., O. S. Awotunde, W. Swiatek, and G. Muszynska. 2001. Protein phosphatase 2A: variety of forms and diversity of functions. Acta Biochim. Pol. 48: 921-933. (Pubitemid 33602348)
33. Wadzinski, B. E., W. H. Wheat, S. Jaspers, L. F. Peruski, Jr., R. L. Lickteig, G. L. Johnson, and D. J. Klemm. 1993. Nuclear protein phosphatase 2A dephosphorylates protein kinase A-phosphorylated CREB and regulates CREB transcriptional stimulation. Mol. Cell. Biol. 13: 2822-2834. (Pubitemid 23133954)
34. Sunahori, K., Y. T. Juang, and G. C. Tsokos. 2009. Methylation status of CpG islands flanking a cAMP response element motif on the protein phosphatase 2Ac alpha promoter determines CREB binding and activity. J. Immunol. 182: 1500-1508.
35. Tan, E. M., A. S. Cohen, J. F. Fries, A. T. Masi, D. J. McShane, N. F. Rothfield, J. G. Schaller, N. Talal, and R. J. Winchester. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25: 1271-1277. (Pubitemid 13221242)
36. Bombardier, C., D. D. Gladman, M. B. Urowitz, D. Caron, C. H. Chang; The Committee on Prognosis Studies in SLE. 1992. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum. 35: 630-640.
37. Esteller, M. 2008. Epigenetics in cancer. N. Engl. J. Med. 358: 1148-1159.
38. Richardson, B., and R. Yung. 1999. Role of DNA methylation in the regulation of cell function. J. Lab. Clin. Med. 134: 333-340.
39. Sawalha, A. H. 2008. Epigenetics and T-cell immunity. Autoimmunity 41: 245-252. (Pubitemid 351593855)
40. Wilson, C. B., E. Rowell, and M. Sekimata. 2009. Epigenetic control of Thelper- cell differentiation. Nat. Rev. Immunol. 9: 91-105.
41. Wilson, A. S., B. E. Power, and P. L. Molloy. 2007. DNA hypomethylation and human diseases. Biochim. Biophys. Acta 1775: 138-162. (Pubitemid 44881198)
42. Pan, Y., and A. H. Sawalha. 2009. Epigenetic regulation and the pathogenesis of systemic lupus erythematosus. Transl. Res. 153: 4-10.
43. Januchowski, R., J. Prokop, and P. P. Jagodzinski. 2004. Role of epigenetic DNA alterations in the pathogenesis of systemic lupus erythematosus. J. Appl. Genet. 45: 237-248. (Pubitemid 38834576)
44. Sekigawa, I., M. Kawasaki, H. Ogasawara, K. Kaneda, H. Kaneko, Y. Takasaki, and H. Ogawa. 2006. DNA methylation: Its contribution to systemic lupus erythematosus. Clin. Exp. Med. 6: 99-106. (Pubitemid 44630739)
45. Patel, D. R., and B. C. Richardson. 2010. Epigenetic mechanisms in lupus. Curr. Opin. Rheumatol. 22: 478-482.
46. Hermann, A., H. Gowher, and A. Jeltsch. 2004. Biochemistry and biology of mammalian DNA methyltransferases. Cell. Mol. Life Sci. 61: 2571-2587. (Pubitemid 39586518)
47. Gorelik, G., J. Y. Fang, A. Wu, A. H. Sawalha, and B. Richardson. 2007. Impaired T cell protein kinase C delta activation decreases ERK pathway signaling in idiopathic and hydralazine-induced lupus. J. Immunol. 179: 5553-5563.
48. Pan, W., S. Zhu, M. Yuan, H. Cui, L. Wang, X. Luo, J. Li, H. Zhou, Y. Tang, and N. Shen. 2010. MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J. Immunol. 184: 6773-6781.
49. Park, B. L., L. H. Kim, H. D. Shin, Y. W. Park, W. S. Uhm, and S. C. Bae. 2004. Association analyses of DNA methyltransferase-1 (DNMT1) polymorphisms with systemic lupus erythematosus. J. Hum. Genet. 49: 642-646. (Pubitemid 40385254)
50. Zhao, M., Y. Sun, F. Gao, X. Wu, J. Tang, H. Yin, Y. Luo, B. Richardson, and Q. Lu. 2010. Epigenetics and SLE: RFX1 downregulation causes CD11a and CD70 overexpression by altering epigenetic modifications in lupus CD4+ T cells. J. Autoimmun. 35: 58-69.
51. Burzynski, M., S. Duriagin, M. Mostowska, M. Wudarski, H. Chwalinska- Sadowska, and P. P. Jagodzinski. 2007. MTR 2756 A > G polymorphism is associated with the risk of systemic lupus erythematosus in the Polish population. Lupus 16: 450-454. (Pubitemid 47122221)
52. Hite, K. C., V. H. Adams, and J. C. Hansen. 2009. Recent advances in MeCP2 structure and function. Biochem. Cell Biol. 87: 219-227.
53. Matouk, C. C., and P. A. Marsden. 2008. Epigenetic regulation of vascular endothelial gene expression. Circ. Res. 102: 873-887. (Pubitemid 351591544)
54. Sawalha, A. H., R. Webb, S. Han, J. A. Kelly, K. M. Kaufman, R. P. Kimberly, M. E. Alarcon-Riquelme, J. A. James, T. J. Vyse, G. S. Gilkeson, et al.. 2008. Common variants within MECP2 confer risk of systemic lupus erythematosus. PloS One 3: e1727.
55. Zhou, Y., J. Yuan, Y. Pan, Y. Fei, X. Qiu, N. Hu, Y. Luo, W. Lei, Y. Li, H. Long, et al.. 2009. T cell CD40LG gene expression and the production of IgG by autologous B cells in systemic lupus erythematosus. Clin. Immunol. 132: 362-370.
56. Ogasawara, H., M. Okada, H. Kaneko, T. Hishikawa, I. Sekigawa, and H. Hashimoto. 2003. Possible role of DNA hypomethylation in the induction of SLE: Relationship to the transcription of human endogenous retroviruses. Clin. Exp. Rheumatol. 21: 733-738. (Pubitemid 38008756)
57. Tian, J., A. M. Avalos, S. Y. Mao, B. Chen, K. Senthil, H. Wu, P. Parroche, S. Drabic, D. Golenbock, C. Sirois, et al.. 2007. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol. 8: 487-496. (Pubitemid 46605917)
58. Yasuda, K., C. Richez, M. B. Uccellini, R. J. Richards, R. G. Bonegio, S. Akira, M. Monestier, R. B. Corley, G. A. Viglianti, A. Marshak-Rothstein, and I. R. Rifkin. 2009. Requirement for DNA CpG content in TLR9-dependent dendritic cell activation induced by DNA-containing immune complexes. J. Immunol. 183: 3109-3117.
59. Juang, Y. T., Y. Wang, G. Jiang, H. B. Peng, S. Ergin, M. Finnell, A. Magilavy, V. C. Kyttaris, and G. C. Tsokos. 2008. PP2A dephosphorylates Elf-1 and determines the expression of CD3zeta and FcRgamma in human systemic lupus erythematosus T cells. J. Immunol. 181: 3658-3664.
60. Khew-Goodall, Y., R. E. Mayer, F. Maurer, S. R. Stone, and B. A. Hemmings. 1991. Structure and transcriptional regulation of protein phosphatase 2A catalytic subunit genes. Biochemistry 30: 89-97.
61. Stone, S. R., J. Hofsteenge, and B. A. Hemmings. 1987. Molecular cloning of cDNAs encoding two isoforms of the catalytic subunit of protein phosphatase 2A. Biochemistry 26: 7215-7220.
62. Baharians, Z., and A. H. Schönthal. 1998. Autoregulation of protein phosphatase type 2A expression. J. Biol. Chem. 273: 19019-19024. (Pubitemid 28366293)
63. Schild, A., L. M. Ittner, and J. Götz. 2006. Altered phosphorylation of cytoskeletal proteins in mutant protein phosphatase 2A transgenic mice. Biochem. Biophys. Res. Commun. 343: 1171-1178.
64. Conkright, M. D., E. Guzmaán, L. Flechner, A. I. Su, J. B. Hogenesch, and M. Montminy. 2003. Genome-wide analysis of CREB target genes reveals a core promoter requirement for cAMP responsiveness. Mol. Cell 11: 1101-1108. (Pubitemid 36566330)
65. Huang, P. H., D. Wang, H. C. Chuang, S. Wei, S. K. Kulp, and C. S. Chen. 2009. alpha-Tocopheryl succinate and derivatives mediate the transcriptional repression of androgen receptor in prostate cancer cells by targeting the PP2AJNK- Sp1-signaling axis. Carcinogenesis 30: 1125-1131.